HomeVideos

Juan Carlos Izpisua Belmonte, Altos Labs | All-In Summit 2024

Now Playing

Juan Carlos Izpisua Belmonte, Altos Labs | All-In Summit 2024

Transcript

757 segments

0:00

[Music]

0:00

scientists think they found the Fountain

0:02

of Youth what I think will become the

0:04

cover story on magazines that humans

0:07

have discovered the Fountain of Youth

0:09

and this will arise from yamanaka Factor

0:11

based cell reprogramming methods it

0:14

feels like a piece of technology that's

0:16

fallen through a wormhole from the

0:17

future it does sound a little bit like

0:19

science fiction A3 billion investment

0:21

that was just made in Altos Labs which

0:23

is probably one of the biggest seed

0:24

Investments ever he has made seminal

0:27

contributions to understanding stem cell

0:30

reprogramming so at this time it's my

0:32

pleasure to introduce our uh recipient

0:35

this year Juan Carlos espia

0:39

[Music]

0:39

[Applause]

0:41

[Music]

0:46

belante good afternoon my name is Juan

0:50

Carlos

0:51

Belmonte I'm going to start my

0:54

participation with a rather provocative

0:57

question which is

1:00

can we rejuvenate an

1:03

organism and if so what is the

1:07

implication of that respon for human

1:10

health for human

1:14

disease so the the book of Our Lives is

1:19

given to us when we are born our parent

1:22

past has this set of instruction these

1:25

millions and millions of letters that

1:28

constitute our

1:30

genome and by and large this is a very

1:34

solid process but every now and then

1:37

there is mistakes in these

1:40

letters and they may have importance for

1:42

our life or may be

1:45

irrelevant let me give you an example

1:47

for instance you change in this

1:51

case a c to a

1:54

t you're going to have a phenotype that

1:57

is depe here the these kids they are in

2:01

the picture between 6 and 10 years old

2:04

but they look much older they're really

2:08

all and they're not going to pass their

2:11

teenage H age and just because of this

2:15

small mutation a c into a

2:18

t now fortunately in the last few years

2:23

we scientists have developed method by

2:27

which we can reverse that change we can

2:30

fix that mistake and for instance we

2:34

have models in the lab we have animal

2:36

models in this case is a mouse where we

2:39

have created the same

2:42

mutation the C into a t and this mouse a

2:46

lab mouse lives for about 2 years this

2:49

mouse will live just for a couple of

2:52

month three four months maximum and it

2:55

will have the same accelerated aging

2:57

process of the human but we can fix this

3:01

we can change this T back into a c and

3:05

we get this mouse which has nothing to

3:07

do with the previous Mouse is healthier

3:11

live longer and is able to regenerate

3:15

some of their tissues that before it

3:17

couldn't do

3:20

it the problem as I was indicating

3:23

before is that

3:26

um this is a very small percentage of

3:30

the mistakes that happen in our life by

3:33

and large this is less than 1% there is

3:36

mistakes that generate diseases like

3:39

this by and large we have many other

3:43

diseases that are not due to a mutation

3:45

in our

3:47

genome and if we look at this graphic

3:50

that represent age and the possibility

3:54

of

3:55

death you can see that after certain

3:58

number of years around 4

4:01

45 the major risk factor for getting any

4:05

disease is precisely that years

4:10

age so the

4:12

longer we live The increased risk to get

4:15

diseased and around 40 45 we start to

4:19

develop all these diseases that you see

4:21

at the top of the

4:22

screen and they are not related to

4:25

changes into C or a t or a particular

4:29

mutation so how this

4:31

happen how these diseases appear and

4:35

what can we do about reversing these

4:39

diseases so let's go down to the cell

4:44

level here you have two type of cells a

4:48

very young cell healthy

4:51

cell and an all an unhealthy

4:55

cell the healthy cell is very res

4:59

resilien in the presence of risk factors

5:03

it has a very strong buffer capacity we

5:06

call that that can deal with

5:09

these these stresses however the all an

5:14

unhealthy cell in addition to the fact

5:17

that has been exposed because of time to

5:20

more factors excuse me it has less

5:24

buffer capacity it's less resilient to

5:27

these factors that damage reach the

5:32

cell and the question

5:35

that I want to present today has to deal

5:39

with this buffer capacity and what is

5:42

buffer capacity let's see if I can

5:44

explain this well so with time as time

5:49

passes there is more risk factors during

5:52

normal aging there is more stress and

5:55

the buffering capacity the resilient of

5:58

these cells goes go down and when these

6:01

two arrows these two curve mix the Seas

6:07

appear and the question is can we

6:10

increase buffer capacity so that then

6:14

the disease appears later or it never

6:18

appear can we increase the cell

6:21

resilience to deal with the disease that

6:24

appearing with aging when we are

6:27

young we really don't think about AG

6:29

when we are all a big percentage of our

6:32

days is just thinking how bad I feel and

6:35

what can I do so can we increase this

6:37

buffer capacity so that disease doesn't

6:41

appear it takes longer to appear or we

6:43

can even reverse it and how can this be

6:50

done just pause for a moment what is

6:53

aging what makes that cell fragile

6:56

unhealthy many things our metab po

7:00

change with

7:01

ag our energy levels drop our

7:05

mitochondria don't produce that ATP that

7:07

is needed for the cell to work

7:10

properly stem cells in our body die many

7:14

things happen while we

7:16

age but I'd like to Poe the idea that

7:19

among all these things that happen

7:21

during aging there is one very important

7:25

thing that could help to increase this

7:27

buffer capacity and this has to do with

7:30

what we call the epig

7:34

genome Epi comes from the Greek above

7:38

above our genome above the instructions

7:40

that we receive from our

7:43

parents and if we look at the cell and

7:48

the The genome the DNA of of any cell is

7:53

is very big it will take approximately 6

7:55

ft if we were to extend it

7:58

here but we need to pack it inside a

8:00

cell and it has a special

8:03

conformation bounded by the specific

8:06

proteins which in a very basic way we

8:10

can divide it in in a confirmation that

8:12

is open for business that we call open

8:15

chromatin or close for business close

8:20

chromatin and just this changing the

8:24

conformation of the chromatine may have

8:26

huge effect in the health

8:30

of the cell and the

8:33

organism in the time when the disease

8:36

appears and the first and most important

8:39

experiment to demonstrate this was done

8:42

by Dr s

8:44

yamanaka where what he did was a very

8:47

simple experiment he took four

8:50

genes added to an adult cell a cell that

8:54

is fragile that is

8:56

unhealthy and make that cell an

8:59

embrionic like cell

9:02

again and he did this by changing this

9:06

confirmation of the

9:09

chromatin now can this help us this

9:13

experiment for which he was awarded the

9:15

Noel price can this help us deal with

9:18

the problem I am trying to convey today

9:20

reverse disease bring back time and make

9:24

the cell more resilient and healthy

9:27

again so through a few years of studies

9:31

the message is this that there is a

9:33

correlation between the conformation of

9:36

the chromatin aging and disease when the

9:39

epigenome when the chromatine is closed

9:42

we call this

9:43

heterochromatin the cell is Young is

9:46

healthy when the chromatin is open it

9:50

leads

9:51

to the increase the loss of buffer

9:54

capacity and therefore disease and aging

9:58

and the question is can we reverse that

10:01

can we this correlation can we do

10:04

something to alter the confirmation of

10:06

this chromatin and demonstrate that just

10:08

by bringing an open chromatine to a

10:11

closed chromatine we can rejuvenate a

10:14

cell and how do we do that we took

10:18

advantage

10:20

of the initial ideas and studies of s

10:25

yamanaka and using again this mouse

10:29

model that I indicated before this

10:32

animal that has a

10:34

mutation that has a c into a te that

10:37

leads to an accelerated aging you can

10:40

see the animal here doesn't have hair

10:42

it's small it's not going to leave for

10:45

too long and what we did we took these

10:48

four factors So-Cal yamanaka factors and

10:52

put it inside this mouse this old mouse

10:55

we're not fixing the mutation remember

10:57

at the beginning there is Technologies

11:00

by which we can fix the mutation what

11:02

we're doing here is just altering the

11:05

chromatin the mutation is still there in

11:08

this mouse the cause of the problem that

11:10

letter is still there not fixed but

11:13

we're altering the

11:15

chromatin and we do this not

11:17

continuously we just do short pulses of

11:20

the yamanaka factors we put just during

11:23

the weekend we put these factors not

11:25

during the entire week to this mouse and

11:27

what happen is that we get a very

11:29

different Mouse healthy mouse that is

11:32

able to live

11:35

longer and remember we have not fixed

11:37

the mutation the te is still there so

11:42

just by this small change in the

11:44

chromatin we can rejuvenate a

11:48

mouse and here is the just example of

11:52

what I'm telling you we can either with

11:54

very precise tools that we have

11:57

developed correct bre a specific

12:00

mutation at the top the C to a t or

12:04

without knowing the mutation just that

12:07

we know that this Mouse has a problem we

12:10

just alter the status of the chromatine

12:13

and we practically get the same

12:15

phenotype we get Rejuvenation on this

12:18

mouse either genome correction or

12:21

epigenome buffering increasing the

12:24

capacity the buffering capacity of this

12:27

mouse so we have gone through from the

12:29

initial point to a later point where the

12:32

mouse will live longer and will have a

12:36

healthier

12:37

life now anyone could tell me yes you

12:40

are telling me just about one case this

12:43

particular mouse that has this mutation

12:46

does it work for something else for

12:49

other

12:50

diseases and the answer is yes let me

12:53

tell you just one more example and a few

12:56

others in a summary here we have another

12:59

mutation these mice have a mutation in a

13:02

gene called

13:04

leptine which make these mice eat all

13:07

the time and as such they get fat they

13:11

change their metabolism they get older

13:13

faster Etc if we just give a short pulse

13:17

of these yamanaka factors we get this

13:20

mouse the mouse still keeps eating

13:22

because it has the mutation we haven't

13:25

corrected but the mouse now has less fat

13:28

in the the liver and can respond to

13:31

glucose like a

13:33

normal young and healthy

13:35

Mouse and if we extend now and I don't

13:38

have time to go through this to many

13:40

other diseases that we have test in the

13:43

lab kidney disease skin disease liver

13:46

disease muscle disease Etc the same

13:50

thing happen we can bring back this

13:53

buffer capacity and make the cell

13:55

younger and the mouse younger

14:00

there's a sentence there that says a

14:02

deceased agnot this approach when you

14:05

are you have a problem you have a

14:08

disease you go to the doctor and it give

14:11

you a medicine but if you have another

14:14

disease it give you another medicine if

14:16

we have a mouse with a mutation we try

14:19

to correct that mutation another mouse

14:22

with another disease we correct that

14:24

mutation but what I'm telling with this

14:26

slide is that independent of the disease

14:30

just by this small switch of changing

14:33

the chromatin we can

14:37

increase the capacity of resilience of

14:40

this mouse so that the disease takes

14:43

longer or is even

14:46

reverse I think this is a very profound

14:49

message that is not very precise we are

14:53

not touching the genome we're touching

14:55

the epigenome but without this Deion we

15:00

can revert

15:01

disease now the key question is this is

15:04

great I told you can we rejuvenate an

15:06

organism at the beginning it seems that

15:10

based on this and other

15:12

experiments in Rodin in the lab the

15:15

answer is yes we take mice with

15:17

different pathologies we pass them

15:20

through these short pulses of yamanaka

15:22

factors and they they're better the the

15:26

disease takes longer to appear they live

15:28

longer

15:30

but even though in science this this

15:33

animal is the one that we know more

15:34

about health and disease much more than

15:37

humans our interest is healthy people

15:42

would this work in humans and this is

15:46

our mission in Aldos try to by this

15:51

cellular Rejuvenation

15:54

programming increase the buffer capacity

15:56

of a human cell so that the Sease is

16:00

reversed or can take longer to

16:03

appear we have done this in isolated

16:07

human cells in the

16:09

petrides but the next step is to move to

16:12

a human being an entire organism like

16:15

the

16:16

mouse and this has to be done so that

16:19

there is with all the safety and all the

16:22

precautions so that we do not harm when

16:26

this experiment is done these mice are

16:28

healthy healthy they're fine there is

16:30

nothing wrong with them but we need to

16:32

really be very cautious when touching a

16:37

human

16:38

cell so rather than delivering these

16:42

factors inside inv Vivo of a human being

16:47

what if we do it ex Vio and here is an

16:51

example organ transplant we know that

16:55

organ donations save thousands and

16:57

thousands of lives every year in our

17:01

planet but nonetheless there are many

17:05

thousands of organs that are discarded

17:08

because their quality because they are

17:10

all the doctor when the organ

17:14

comes look at the organ and said this is

17:17

this organ is not good enough doesn't

17:19

have enough quality to be transplanted

17:22

and it just get

17:24

discarded what if instead of going

17:27

directly into a human being we try to

17:30

rejuvenate this organ that is

17:32

discarded and see if the doctor now will

17:35

say now this organ is ready to be

17:38

transplanted whatever conditions and

17:40

quality requir by this doctor and we are

17:43

making progress into this area you can

17:47

see here when we

17:50

transplant ER in this case is still in

17:53

Rodin an all

17:56

kidney into a young rat and we compare

18:00

this with the transplantation of a young

18:02

kidney the life of the horse is very

18:05

different you see these two the green

18:08

and the blue lines so the

18:12

blue line is with no treatment the green

18:16

line is after a short pulse of these

18:19

factors that is given X Vivo to this

18:23

organ before it's transplanted and that

18:25

lead to an increase in the survival of

18:28

the hor so that's one way to start

18:32

approaching of moving this technology

18:35

that we are developing in the lap in

18:36

mice into humans but at the same time

18:41

there's one thing that and I'm finishing

18:43

there is one thing that I would like to

18:46

stress it's not that all the cells of

18:50

our organism go bad with time otherwise

18:53

we'll be dead there just a few cells and

18:57

with time there is more and more of

18:59

these fragile unhealthy cells that don't

19:02

have enough buffer capacity and you can

19:05

see this in this diagram the blue dots

19:08

indicate that with time we have more and

19:11

more of these nonfunctional cells but

19:14

what we don't want to touch is what is

19:17

working we don't want to deliver these

19:20

factors to cells that are healthy and

19:23

that are

19:24

functional how do we deliver these

19:26

factors just to those cells that are not

19:28

work work into these blue cells so you

19:31

see here the two H situation in a y

19:35

tissue you almost don't have any of

19:37

these fragile and healthy cells and how

19:40

can we deliver the factors just in the

19:44

age situation to the unhealthy cells but

19:47

we don't touch we don't want to touch

19:49

the healthy cells and this is what we we

19:52

have been doing there is a specific

19:55

genes and markers that Target and

19:58

identify by the unhealthy cell and with

20:01

these markers we can guide our yamanaka

20:04

factors just to the unhealthy cell and

20:07

we obtain the same phenotype you can see

20:09

here an increase in life span just

20:12

targeting the unhealthy cell increasing

20:15

the buffering capacity of the unhealthy

20:17

cell and the last slide that I want to

20:20

show you is for instance an organ like

20:23

the skin if we bring these factors to

20:28

the non healthy cell of the skin you see

20:31

phenotypes like this for instance an old

20:33

mouse like us with time will get gray

20:37

hair it would just bring the factors to

20:41

the unhealthy cells of the of the skin

20:44

that

20:46

produce this deterioration of function

20:50

now you see that the gray hair doesn't

20:53

appear or if we do a wound in the skin

20:56

of an animal of an animal and this in us

21:02

after a certain age the wound takes a

21:05

long time to close or even it doesn't

21:08

close you can see at the top the

21:09

nontreated in red there is there is a

21:12

wound there that has doesn't heal while

21:16

the treated one even in a very very old

21:19

mouth it just make a perfect Skin So

21:23

summary of what I have told you today is

21:26

this that

21:28

there is what we call Precision Medicine

21:31

by which we

21:33

can fix some of these mutations errors

21:37

that our parent transmit into the book

21:40

of our life but that's less than 1% of

21:43

the diseases the majority of diseases

21:46

correlate with

21:48

age passing of the time and they don't

21:51

have anything to do with particular

21:55

mutations and without touching the

21:57

genome with this Precision medicine just

22:01

just modifying the conformational

22:04

structure of the chromatin we can bring

22:08

a disease and aged cell into a cell that

22:12

is more resilient and more functional

22:15

and certainly this type of experiment

22:18

and the messages that it open up the

22:21

question of can we rejuvenate a human

22:24

being and can we reverse diseas in human

22:27

thank you for your

22:28

[Applause]

22:39

right ju caros thank you for the

22:42

presentation I want to I I don't I don't

22:44

know if you can

22:45

overstate the significance of the

22:48

discovery you have made and it's funny

22:51

to me how it's not popular uh knowledge

22:55

at this point because of the results

22:58

that you and other

23:00

scientists have collected and the impact

23:02

it will have to literally restore uh

23:06

cellular health and and deage an

23:09

organism and um the yamanaka factors or

23:13

four proteins just just for Layman's

23:15

conversation there are four proteins

23:17

that's what a factor is it's a A protein

23:21

that causes a change in the epigenome

23:23

and unwinds parts of the DNA and as a

23:25

result new genes get turned on other

23:27

genes get turned off and the cell kind

23:29

of revitalizes it becomes young

23:32

again um you discovered that you can

23:37

actually and and they did this all the

23:38

and made the cells go back all the way

23:39

to being stem cells but what you

23:41

discovered was the ability to partially

23:43

ReStore youthfulness in the cells

23:45

through partial reprogramming and that's

23:47

a dose Factor you put a smaller amount

23:50

of the yanaka factors on the cells what

23:52

how do you control it and then I want to

23:53

ask a question um about if you put too

23:57

much does it then because I know there's

23:58

been tests in mice where you end up with

24:00

cancer because then the cells start

24:01

multiplying too quickly so maybe you can

24:02

tell us a little bit about what it means

24:03

to do partial reprogramming with the

24:06

amak what does partial mean very

24:09

important question thank you for let's

24:12

see if I can clarify this what Dr s

24:15

yamanaka did is something that we no one

24:18

in in science in general could believe

24:21

that you can bring an adult

24:24

cell to a start life again become an

24:30

embryo cell embryol likee cell an

24:33

embryonic stem cell can be whatever we

24:36

have more than 250 cell types in our

24:40

body our skin cell is different than our

24:43

eye cell is different than our brain

24:44

cell because different genes are turned

24:46

on and off in each of those cells they

24:49

have the same DNA but they have a

24:50

different epigenome different genes are

24:52

turned on perfectly explained thank you

24:54

so and

24:56

what I think it's so for people to get

24:59

that yeah what SAA did was just to

25:02

delete delete all that information the

25:04

identity of a skin cell of a heart cell

25:08

and bring it back to the very beginning

25:10

to the to the very first time when we

25:13

are born to this type of cells

25:16

now is when he was putting these factors

25:20

it's his factors the yamanaka factor for

25:22

a long time four proteins for four prot

25:25

four proteins put them on the cell this

25:26

happens now we don't want this imagine

25:30

if we were to put this in the

25:32

heart the key cell in the heart is

25:34

called cardom myosite and what it does

25:37

is beat so if we remove the identity

25:41

can't of that cell is not anymore a

25:44

cardom myosite and go back to an

25:46

embryonic cell the heart is not going to

25:50

beat if we do that in the liver theoy is

25:54

not going to do its function so doing

25:58

this going back in in time to really the

26:01

earli

26:03

stages it will not do good to our bodies

26:08

and then and cancer arises and then if

26:10

you bring and lose the identity of a

26:12

particular cell then you are open for

26:15

that cell to become something else right

26:18

like a cancer cell or a skin cell is

26:21

transformed into aite many wrong things

26:24

could happen we want to maintain the

26:27

identity of this cell

26:29

and the small switch here that we did as

26:32

you are asking me is rather than having

26:35

the factors for a long time we just gave

26:37

a short

26:39

pulse what that is doing is altering the

26:44

chromatin but for a very short time it's

26:47

a small shock and then the chromatin get

26:49

close and maintain its

26:53

identity the cardiomyocyte is a cardom

26:56

myosite has not gone back

26:59

to a different cell typee but its

27:01

function is much better this is so the

27:04

idea is just a short P of these proteins

27:07

which by the way these are the proteins

27:10

that s yamanaka discovered but I'm

27:12

convinced that there will be many other

27:15

proteins so that's organism that's the

27:17

next thing I wanted to ask you so it

27:19

sounds like the search is on in various

27:21

startups at Alto slabs for other

27:24

proteins that can do this but perhaps

27:27

not protein but smaller molecules

27:30

peptides or small molecules where

27:33

theoretically you could take a

27:35

pill and it would do the same thing is

27:40

that a

27:42

reality so I think that one of the

27:46

biggest inventions that we humans have

27:48

made is the place we're here today the

27:52

university the Curiosity the knowledge

27:55

to advance in things that we don't

28:00

understand um

28:02

and discovering what other proteins what

28:05

other factors could do the same thing

28:08

belongs to that domain of the Curiosity

28:11

and trying to increase our knowledge but

28:14

many times we need to try to apply this

28:16

knowledge and you're asking me how are

28:19

you going to deliver whatever factors

28:22

you discover into a human

28:24

being you can do this in the lab with

28:27

many other ways but ideally you would

28:29

like to just put that into

28:32

appeal and so here is where the other

28:35

important thing come and that's

28:39

industry by mixing the Bas

28:43

of

28:45

Academia this curiosity this trying to

28:48

understand how we can close and open the

28:49

chromatin with many other

28:52

factors with the experience the drive

28:55

and the focus of

28:57

Industry can we answer the question that

28:59

you are asking can we put these factors

29:02

or any other factors that alter the

29:05

chromatine into appeal this is precisely

29:09

our Endeavor try to make this safe and

29:12

available to can I ask you a more maybe

29:16

a more basic

29:17

question um if this buffer

29:22

capacity is essentially the insulation

29:25

that we are born with that then decays

29:27

so

29:28

young cell good buffer capacity old cell

29:31

no buffer capacity in very simple terms

29:33

based on your side what is the

29:37

scientific community's understanding

29:40

about how to minimize the rate of change

29:44

and the Decay by things that people in

29:47

this room can control where we live the

29:49

things that we're exposed to our food

29:51

supply do any of those things to your

29:55

understanding have an impact that's

29:57

measurable

29:59

and achievable by us today while we wait

30:01

for altos and others to deliver more

30:03

chemical manipulation of this huge

30:05

impact incredible question and really

30:08

huge impact just think of exercise we

30:11

have compare what are the changes in the

30:14

Cell between

30:17

exercise and the short pulses of Y Mana

30:20

factors and you couldn't believe the

30:23

similarities in the changes in gene

30:25

expression that exercise

30:28

th and how overlap these changes happen

30:33

when we do the yamanaka the sh PES of

30:36

yamanaka factors so things like exercise

30:40

but exercising what kind of exercise how

30:42

much how

30:43

often why you want to know the answer

30:45

too what don't laugh actually you know

30:47

what don't answer the question you can

30:49

tell us afterwards because they don't

30:50

care don't it's

30:51

[Applause]

30:53

fine and exercise things that your

30:56

mother will tell you eat less

31:00

exercise H when I say stress I mean it

31:03

stress to the cell that is going to

31:05

alter the epigenome so until we really

31:10

understand how these changes in

31:12

chromatine happen all these things that

31:15

we do sometime with our life really

31:18

improve the buffer capacity and has that

31:20

been published or studied in a way

31:22

that's digestible for Layman meaning

31:25

like whether it's intermittent fasting

31:27

or whether it's the the quantity of food

31:29

or whether it's you know specific forms

31:31

of exercise over another has that been

31:33

well studied enough that we can at a

31:36

minimum we can even just link to all of

31:37

this so that you guys can get this

31:39

information but is it out there this is

31:41

I would say the last 10 years have been

31:44

an

31:46

incredible jump into into these studies

31:50

so far most of them have been done in

31:53

animal models in the lab and we are

31:57

starting to translate this to humans um

32:01

for instance I just finish it's not I

32:06

think I can say that tomorrow it will be

32:08

just one of these molecules that

32:12

diabetic people take metformine to lower

32:15

down their glucose they can reprogram

32:18

the cells so that all the cognitive

32:21

function or not just rodents and this is

32:23

the key thing but of monkeys which are

32:27

99% % their book of life is very 99 9%

32:32

similar to us right it can reprogram

32:34

these cells and the cognitive abilities

32:37

of monkeys and their lifespan is

32:40

increased so this is coming this is not

32:44

something that is just this small Mouse

32:48

in the lab where we know a lot about

32:50

their health and disease but I feel the

32:53

next decade probably many of these

32:56

discoveries with the caveat that it's a

32:59

mouse and a mouse is not a human might

33:01

be translated to human you put a slide

33:03

up there where you had a obviously a

33:05

whole bunch of Target markets some were

33:08

autoimmune diseases some were cancers

33:11

some were more just general aging

33:15

um how do you decide or how do you

33:18

figure

33:19

out where there is the uh most real

33:24

application today because I part of it

33:26

is there's a obviously

33:28

Market issue of making sure you continue

33:30

to have capital and prove scientific

33:32

value but part of it is there may be

33:34

some small winds today in rare diseases

33:37

or something that could allow you to

33:39

commercialize this faster so how do you

33:41

think about which problems should come

33:47

first good question I put up there the

33:51

ex Vio example with the organ

33:56

transplant this is probably one of the

33:58

most cautious and safest safest approach

34:02

where say uh acute liver disease there's

34:07

nothing about this you're are going to

34:08

die in 3 days right and if an organ is

34:11

not there you can do nothing so acute

34:15

and and deadly diseases that could

34:18

happen could be an

34:20

initial um target for these type of

34:24

approaches um but again I I want to say

34:29

that even though we are trying to move

34:34

as fast as we can into humans and we are

34:36

doing this experimen in human cells in

34:39

the Petri a mouse is not a human and

34:42

this will need time to be replicated in

34:45

a human being before we wrap can we just

34:47

talk about how altto Labs is set up it's

34:51

probably got more funding than any other

34:53

private company in recent history it's

34:57

really incredible how the the maybe you

34:58

can tell us how how you've organized

35:00

this this work this Mission um and again

35:04

is reflecting on the importance that we

35:07

know so little and about the fundamental

35:11

science of what is behind this big

35:15

question is a question that we human

35:17

beings have have tried to approach since

35:20

ever how can we deal with disease with

35:24

aging so there is so many things we

35:27

don't no basic sign is needed so as a

35:30

startup you raised billions of dollars

35:32

to do a lot of core research as well as

35:35

product development and at the same time

35:37

in parallel yeah with all the safety

35:40

approaches that we can think of and we

35:43

were talking about one possible

35:45

example perhaps without knowing every

35:49

detail of how it works provided is safe

35:53

and could have a positive effect trying

35:55

to move this forward so it's a

35:57

combination of what we like to call the

36:01

base of basic science and the base of

36:04

Industry yeah well look I mean I don't

36:06

think there's a human on earth that will

36:08

uh not benefit and does not appreciate

36:11

the the effort and and obviously

36:12

everyone hopes that you guys are

36:15

extremely successful in both the

36:17

scientific and Commercial uh Pursuits I

36:20

it seems to me like as you guys have

36:22

your breakthroughs which I think you're

36:25

uh you're going to have given the

36:27

backing and people that are involved

36:29

over time uh partial cell reprogramming

36:33

could be one of the most profoundly

36:34

impactful technologies that humans have

36:38

ever discovered or invented so we

36:39

appreciate the work that you do and and

36:41

thank you for being here with us thank

36:43

you for thank you

36:46

[Applause]

Interactive Summary

This presentation explores the revolutionary potential of cellular reprogramming to combat aging and age-related diseases. By utilizing 'Yamanaka factors'—proteins that can reset a cell's epigenome—researchers have demonstrated the ability to rejuvenate cells and restore them to a more youthful, resilient state without altering their original genetic code. This approach, specifically 'partial reprogramming,' aims to boost the body's 'buffer capacity' to handle stress and disease. While currently tested in animal models, the mission is to translate these findings into human applications, potentially through ex-vivo organ rejuvenation or targeted treatments for age-associated conditions, while prioritizing safety and efficacy.

Suggested questions

4 ready-made prompts